Please ensure Javascript is enabled for purposes of website accessibility Venture Fund - Janus Henderson Investors
For Individual Investors in the US

Venture Fund Holdings

Full Portfolio Holdings

(As of April 30, 2024)

% OF INVESTMENTS
Stride Inc 2.08
Nice Ltd (ADR) 2.08
SS&C Technologies Holdings Inc 1.98
Descartes Systems Group Inc 1.90
Core & Main Inc 1.80
Blackbaud Inc 1.74
Broadridge Financial Solutions Inc 1.65
LPL Financial Holdings Inc 1.61
Rentokil Initial PLC (ADR) 1.58
CSW Industrials Inc 1.57
Sensient Technologies Corp 1.55
SPX Technologies Inc 1.49
Constellium SE 1.45
OSI Systems Inc 1.38
ON Semiconductor Corp 1.36
WEX Inc 1.36
Valvoline Inc 1.36
Janus International Group Inc 1.34
Alight Inc 1.34
Glaukos Corp 1.31
Vaxcyte Inc 1.27
Globus Medical Inc 1.26
Euronet Worldwide Inc 1.25
ATS Corp 1.22
BellRing Brands Inc 1.22
Tyler Technologies Inc 1.17
Casey's General Stores Inc 1.17
Zurn Elkay Water Solutions Corp 1.15
Paylocity Holding Corp 1.11
Napco Security Technologies Inc 1.08
ITT Inc 1.07
Gates Industrial Corp PLC 1.05
ICON PLC 1.04
Williams-Sonoma Inc 1.04
MACOM Technology Solutions Holdings Inc 1.03
Shift4 Payments Inc 1.01
EnerSys 1.00
Alamo Group Inc 0.98
Innospec Inc 0.96
STERIS PLC 0.96
Repay Holdings Corp 0.94
Lantheus Holdings Inc 0.93
Magnolia Oil & Gas Corp 0.90
Bancorp Inc 0.88
Madrigal Pharmaceuticals Inc 0.87
Ziff Davis Inc 0.87
AvidXchange Holdings Inc 0.86
CRA International Inc 0.84
Monarch Casino & Resort Inc 0.83
Clarivate PLC 0.82
Altair Engineering Inc 0.82
RLI Corp 0.78
WNS Holdings Ltd 0.78
Vertex Inc 0.78
HealthEquity Inc 0.77
Assetmark Financial Holdings Inc 0.77
ICU Medical Inc 0.76
Atlanta Braves Holdings Inc 0.74
Gerresheimer AG 0.73
Ascendis Pharma A/S (ADR) 0.73
Envestnet Inc 0.72
Avadel Pharmaceuticals PLC 0.72
Biohaven Ltd 0.70
Weatherford International PLC 0.70
CACI International Inc 0.68
Ligand Pharmaceuticals Inc 0.68
Loar Holdings Inc 0.66
Enpro Inc 0.65
Montrose Environmental Group Inc 0.64
NeoGenomics Inc 0.62
Ideaya Biosciences Inc 0.61
Perimeter Solutions SA 0.60
Bio-Techne Corp 0.58
Novanta Inc 0.56
Walker & Dunlop Inc 0.56
U-Haul Holding Co 0.55
REVOLUTION Medicines Inc 0.55
Camtek Ltd/Israel 0.52
PDF Solutions Inc 0.52
FirstService Corp 0.51
Nordson Corp 0.51
MSA Safety Inc 0.50
Payfare Inc 0.50
Vivid Seats Inc 0.48
Catalent Inc 0.48
Doximity Inc 0.47
Enfusion Inc 0.47
Halozyme Therapeutics Inc 0.45
BRP Group Inc 0.44
Oddity Tech Ltd 0.44
CECO Environmental Corp 0.43
California Resources Corp 0.42
Cognex Corp 0.42
Alphatec Holdings Inc 0.41
Lovesac Co 0.41
Mirum Pharmaceuticals Inc 0.41
Asure Software Inc 0.40
Thor Industries Inc 0.37
Brady Corp 0.37
Xometry Inc 0.37
Kornit Digital Ltd 0.36
CryoPort Inc 0.36
Neogen Corp 0.36
Paragon 28 Inc 0.35
Tandem Diabetes Care Inc 0.35
Sarepta Therapeutics Inc 0.35
OmniAb Inc 0.32
Soleno Therapeutics Inc 0.32
Amicus Therapeutics Inc 0.32
Insmed Inc 0.32
Bridgebio Pharma Inc 0.31
Shockwave Medical Inc 0.31
Neurocrine Biosciences Inc 0.31
Sotera Health Co 0.28
Apartment List Inc 0.27
Crinetics Pharmaceuticals Inc 0.27
PTC Therapeutics Inc 0.26
Manchester United Plc 0.25
Innodata Inc 0.23
Loadsmart Inc 0.20
Consensus Cloud Solutions Inc 0.20
UL Solutions Inc 0.18
89bio Inc 0.18
Verona Pharma PLC (ADR) 0.17
Claris Ventures SGR SPA 0.16
Rocket Pharmaceuticals Inc 0.16
Computer Modelling Group Ltd 0.13
Structure Therapeutics Inc (ADR) 0.13
Edgewise Therapeutics Inc 0.11
QuantumScape Corp 0.09
IntelyCare Inc 0.08
Loadsmart Inc 0.07
AST SpaceMobile Inc 0.07
Ibotta Inc 0.06
CoreCard Corp 0.04
OmniAb Operations Inc 0.01
OmniAb Operations Inc 0.01
Perimeter Solutions SA 0.00
Cash & Equivalents 0.60
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.